Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Everist Genomics' Companion Tests for Colorectal Cancer

Premium

Everist Genomics has launched four companion diagnostics intended to improve early diagnosis, management, and treatment of patients with colorectal cancer.

The tests, which will be available in the US at the end of March, include:

OncoDefender-MMR, used for prognosis for colorectal cancer patients at all stages of the disease;

OncoDefender-CRC, designed to identify early-stage colorectal cancer patients likely to benefit from adjuvant chemotherapy;

OncoSelector, intended for patients who have tested positive with OncoDefender-CRC and used to help physicians determine which type of chemotherapy a colorectal cancer patient is likely to respond best to — 5-FU or irinotecan; and

OncoDefender-Lynch syndrome, which identifies patients with Lynch syndrome, an inherited disorder that is associated with a high risk of developing colon cancer.

All tests are performed at the company's CLIA-certified laboratory in Ann Arbor, Mich. Everist said that OncoDefender MMR, OncoDefender-Lynch syndrome, and OncoSelector are reimbursable through private insurance and Medicare, subject to individual plan benefits.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.